SNTI - Senti Biosciences, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.08 0.2 (9.62%)	---	0.03 (1.33%)	0.04 (1.79%)	0.03 (1.44%)	0.19 (8.88%)	-0.03 (-1.3%)	-0.03 (-1.3%)

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.56
Diluted EPS:: -0.56
Basic P/E:: -4.0714
Diluted P/E:: -4.0714
RSI(14) 1m:: 100.0
VWAP:: 2.28
RVol:: 3.1156

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.34 +0.03 (+1.3%)	Oct 15 15:54
1m	Price decrease 1m	2.3 -0.03 (-1.23%)	Oct 15 15:50
1m	Price decrease 1m	2.3 -0.03 (-1.29%)	Oct 15 15:47
1m	Price increase 1m	2.38 +0.03 (+1.28%)	Oct 15 15:35
1m	Price increase 1m	2.37 +0.03 (+1.28%)	Oct 15 15:34